Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04589845
Title Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

Therapies

Alectinib

Ado-trastuzumab emtansine

Ipatasertib

GDC-0077

Entrectinib

Atezolizumab

Idasanutlin

Age Groups: senior | adult | child
Covered Countries USA | CAN

Additional content available in CKB BOOST